This autoimmune mechanism is particularly interesting since ALS autoantibodies have been shown to target only CaV1.1, CaV2.1, and CaV2.2 channels prior to the present work (2, 18, 20, , –23). The gene discussed is CACNA1B; the disease is amyotrophic lateral sclerosis.